Core Viewpoint - Trifork Group AG has announced the initiation of a share buyback program aimed at redistributing excess cash to shareholders and potentially reducing share capital through share cancellation in the future [1][2]. Group 1: Share Buyback Program Details - The share buyback program will involve a maximum expenditure of DKK 75 million (approximately EUR 10 million) [1][5]. - The program is set to run from 2 March 2026 to 31 December 2026, with a pause from 13 April to 17 April 2026 [3]. - Danske Bank A/S has been appointed as the lead manager for the share buyback program, making independent trading decisions on behalf of Trifork [4]. Group 2: Execution and Regulations - The maximum number of shares to be repurchased is 1,700,000, which represents 8.6% of the outstanding registered shares of Trifork [5]. - The daily purchase limit is capped at 25% of the average daily trading volume over the preceding 20 trading days [5]. - Shares will be acquired through public trading on Nasdaq Copenhagen, adhering to the EU Market Abuse Regulation and the Safe Harbour Regulation [3][5]. Group 3: Company Overview - Trifork is a global technology company specializing in advanced software solutions for sectors such as public administration, healthcare, financial services, energy, and aviation [6]. - The company employs 1,148 individuals across 16 countries and has a dedicated R&D arm, Trifork Labs, focused on innovation and investment in high-potential technology companies [6].

Core Viewpoint - Trifork Group AG announces changes to its Board of Directors, with Julie Galbo and Maria Hjorth stepping down and new candidates proposed for election at the upcoming AGM [1][2][3]. Group 1: Board Changes - Julie Galbo and Maria Hjorth will not stand for re-election at the upcoming AGM, focusing on other professional commitments [1]. - Both members have served on the Board for nearly six years and have significantly contributed to Trifork's growth, with the company nearly doubling its revenue and EBITDA during their tenure [2]. - Anja Monrad is proposed as the new chairperson, and Danny Lange is proposed as a new member of the Board of Directors [3]. Group 2: Company Overview - Trifork Group is a global technology company specializing in innovative digital products and solutions for enterprise and public sector customers [4]. - The company employs 1,148 people across 16 countries and focuses on advanced software development in various sectors, including public administration, healthcare, financial services, energy, and aviation [4]. - Trifork Labs, the Group's R&D arm, is dedicated to driving innovation by investing in and developing high-potential technology companies [4].

Core Insights - TGS announces the Nigeria Laide multi-client 3D survey in collaboration with NUPRC and SeaSeis Geophysical, covering approximately 11,700 square kilometers in the eastern Niger Delta, a significant hydrocarbon region [1][3] Technology and Methodology - The survey utilizes the GeoStreamer dual-sensor system with long offsets, wide tow, and a triple-source configuration, providing modern broadband seismic data that enhances the evaluation of complex geological structures in the deepwater eastern Niger Delta [2] - Advanced Elastic FWI-driven velocity model building supports full-integrity PSTM and Q-PSDM, enabling operators to address geological challenges such as stacked toe-thrust structures and shale diapirs [2] Strategic Importance - The CEO of TGS emphasizes Nigeria's critical role in the global oil and gas supply, highlighting the company's commitment to hydrocarbon exploration in the region through the Laide 3D survey [3] - The survey is backed by industry funding, indicating strong market interest and support for exploration activities in Nigeria [3]

Core Viewpoint - Luotea Plc has shown significant profitability improvement in continuing operations for the year 2025, following the completion of a partial demerger that separated its Circular Economy business into an independent entity named New Lassila & Tikanoja Plc [1][8]. Continuing Operations - For the fourth quarter of 2025, net sales were EUR 88.7 million, a decrease of 1.2% compared to the previous year [7]. - Adjusted EBITA for the fourth quarter was EUR -0.3 million, representing -0.3% of net sales [7]. - For the full year 2025, net sales totaled EUR 346.0 million, down 1.0% from 2024 [7]. - Adjusted EBITA for the year was EUR 7.0 million, which is 2.0% of net sales, a significant increase from EUR 1.2 million (0.3%) in 2024 [7]. Discontinued Operations - The operating profit for discontinued operations in the fourth quarter was EUR 10.8 million, up from EUR 8.7 million in the previous year [7]. - For the full year, the operating profit of discontinued operations was EUR 44.2 million, compared to EUR 41.6 million in 2024 [7]. Outlook for 2026 - The adjusted EBITA for 2026 is expected to increase significantly compared to the adjusted EBITA of EUR 7.0 million for 2025 [6]. Management Insights - The company focused on customer profitability, product development, and data utilization in service production, leading to improved profitability indicators in a challenging market [8]. - Investments were made in occupational safety and employee training, enhancing leadership and sustainability competencies [9]. - The company achieved a Net Promoter Score (NPS) of 18, indicating improved customer satisfaction [9]. Sustainability and Financial Health - Luotea received a Gold level in ECOVADIS, ranking among the top 2% of assessed companies, reflecting its commitment to sustainability [11]. - The company has low net debt and strong cash flow, allowing for a proposed dividend of EUR 0.07 per share for 2025 [11][14]. Future Goals - Luotea aims for profitable growth as an independent company, targeting EUR 400 million in revenue and an EBITA margin of 5% in the medium term [12].

Core Insights - Lassila & Tikanoja plc successfully demerged on December 31, 2025, into two independent listed companies, marking a significant milestone in its history and allowing a focused development of its circular economy services [6][41]. Financial Performance - For the year 2025, net sales reached EUR 426.6 million, a slight increase of 0.7% compared to the previous year [7][19]. - Adjusted EBITA for 2025 was EUR 40.6 million, representing 9.5% of net sales, down from 10.5% in the previous year [21][23]. - The operating profit for 2025 was EUR 34.2 million, which is 8.0% of net sales, a decrease from 9.5% in 2024 [22][23]. - Earnings per share for 2025 were EUR 0.67, down from EUR 0.83 in 2024 [23][80]. - Net cash flow from operating activities after investments was EUR 41.4 million, an increase from EUR 34.3 million in the previous year [10][27]. Segment Performance - The Waste Management and Recycling service area saw a decline in net sales by 1.8% to EUR 278.1 million due to a challenging economic environment [7][19]. - The Hazardous Waste and Remediation service area experienced a 12.0% increase in net sales to EUR 73.0 million, driven by a strong project pipeline [8][20]. - Net sales in Industrial Services and Water Treatment remained stable at EUR 81.3 million [20]. Acquisitions and Investments - In 2025, the company completed three acquisitions, including the pallet business of Stena Recycling Oy, which is expected to generate annual net sales of approximately EUR 10 million [11][24]. - An investment in a new plastics recycling plant in Merikarvia will increase the company's recycling capacity by approximately 1.5 times [12][25]. Sustainability Initiatives - The company's carbon footprint (Scope 1–2) decreased by 18% compared to the previous year, achieving a significant reduction five years ahead of schedule [13][35]. - The recycling rate of non-hazardous waste rose to 61.8%, supported by higher volumes of pallets and plastics [36]. Future Outlook - For 2026, net sales are estimated to be between EUR 420 million and EUR 450 million, with adjusted EBITA projected to be between EUR 38 million and EUR 44 million [5].

Core Insights - Trifork Group reported a full-year revenue growth of 7.2% for 2025, with an adjusted EBITDA margin of 13.6%, indicating strong performance in the fourth quarter and a positive outlook for 2026 [1][2][5] Financial Performance - Total revenue for 2025 reached EURm 220.9, up from the previous year, with organic growth at 7.0% driven by increased public sector demand and successful product-led engagements [5] - Adjusted EBITDA for 2025 was EURm 30.1, reflecting a margin improvement from 11.9% in 2024 to 13.6% in 2025, attributed to revenue growth and cost savings [5] - EBIT for 2025 amounted to EURm 16.8, with a margin increase from 4.0% in 2024 to 7.6% in 2025, positively impacted by the deconsolidation of Trifork Security [5] - Cash conversion improved significantly to 97.9% in 2025, up from 74.3% in 2024, due to higher profitability and lower net working capital [5] Segment Performance - The Products segment saw a revenue increase of 37.6% to EURm 77.7, with an adjusted EBITDA margin of 20.9%, up from 17.0% in 2024 [5][12] - Services revenue declined by 4.1% to EURm 143.1, with a stable adjusted EBITDA margin of 13.7% [12] - In Q4 2025, total revenue was EURm 59.0, marking a 5.3% increase year-over-year, with organic growth at 9.4% [12] Strategic Initiatives - A share buyback program of up to DKKm 75 (approximately EURm 10) will be initiated to redistribute excess cash to shareholders [9] - A strategic review of options for Trifork Labs is underway, exploring potential divestments or portfolio-level transactions to optimize capital allocation [10][11] Future Outlook - For 2026, the company expects group revenue to be in the range of EURm 230-240, indicating total growth of 4.1-8.7%, with organic growth projected between 6.7-11.3% [12]

Core Insights - The audited annual report for Bigbank AS for 2025 shows no changes from the previously published interim report, confirming the financial results [1] - The report will be submitted for approval to the General Meeting of Shareholders [1] Financial Performance - Total assets increased to 3.3 billion euros, rising by 538 million euros (+19%) [4] - Loans to customers grew to 2.7 billion euros, increasing by 511 million euros (+23%) [4] - The deposit portfolio grew to 2.9 billion euros, increasing by 486 million euros (+20%) [4] - Net profit amounted to 37.9 million euros [4] - Return on equity (ROE) stood at 13.3% [4] Company Overview - Bigbank AS has over 30 years of operating history and is a commercial bank owned by Estonian capital [2] - As of 31 December 2025, the bank serves more than 188,000 active customers and employs over 600 people [2] - Moody's assigned Bigbank a long-term bank deposit rating of Ba1, along with a baseline credit assessment (BCA) and an adjusted BCA of Ba2 [2]

Core Viewpoint - Santhera Pharmaceuticals announces that AGAMREE® (vamorolone) has been proposed for inclusion in the pharmaceutical coverage of the Spanish National Health System, making it eligible for reimbursement [1][2]. Group 1: Product Information - AGAMREE® is approved by the European Commission for treating Duchenne muscular dystrophy (DMD) in patients aged 4 and older [3]. - The drug has been available in Spain through a paid named-patient program since mid-2024 [3]. - AGAMREE is positioned as a dissociative anti-inflammatory drug, offering an alternative to existing corticosteroids, with a mechanism that aims to dissociate efficacy from steroid safety concerns [4]. Group 2: Clinical Data - In the pivotal VISION-DMD study, AGAMREE met the primary endpoint of Time to Stand (TTSTAND) velocity versus placebo (p=0.002) at 24 weeks of treatment, demonstrating a good safety and tolerability profile [5]. - Commonly reported side effects included cushingoid features, vomiting, weight increase, and irritability, generally of mild to moderate severity [5]. - Unlike corticosteroids, AGAMREE shows no restriction of growth and no negative effects on bone metabolism, as indicated by normal serum markers for bone formation and resorption [6]. Group 3: Market Strategy - The company plans to start making AGAMREE available across various regions in Spain from early in the second quarter of 2026, following the acceptance of the draft resolution by the Directorate-General of Pharmacy [2]. - This announcement is seen as a significant milestone in expanding access to AGAMREE for DMD patients in Europe and globally, following commercial launches in Germany, Austria, and the UK [4].

The Supervisory Board of EfTEN Real Estate Fund AS has approved the fund's audited annual report for 2025 and will submit it for approval at the General Meeting of Shareholders. The Fund’s financial results in the audited report have not changed compared to the preliminary financial results published on 29 January 2026. The consolidated sales income of EfTEN Real Estate Fund AS for 2025 was 33.083 million euros, an increase of 845 thousand euros (2,6%) compared to the previous year. The Group's net profit f ...

Core Viewpoint - Lassila & Tikanoja Plc has announced a share repurchase program aimed at supporting share-based incentive schemes and compensating the Board of Directors, with a maximum of 150,000 shares to be repurchased, representing approximately 0.39% of total shares [1][3]. Group 1 - The share repurchase will commence on 2 March 2026 and conclude by 28 April 2026 [1]. - The repurchase will be conducted using the company's unrestricted equity at the market price on Nasdaq Helsinki Ltd, and will not be proportional to existing shareholders' holdings [2]. - The Extraordinary General Meeting on 4 December 2025 authorized the Board to repurchase up to 2,000,000 shares, which is about 5.2% of the total shares, for various purposes including acquisitions and incentive schemes [3]. Group 2 - The total number of registered shares in Lassila & Tikanoja Plc is 38,211,724, and currently, the company does not hold any of its own shares [4]. - Lassila & Tikanoja is a leading Nordic circular economy company focused on waste management, recycling, and promoting sustainable material use, employing approximately 2,300 people in Finland and Sweden [5].